Dimethyl 3,3'-(2-(2-(diphenylphosphanyl)-1H-pyrrol-1-yl)-1,3-phenylene)dipropionate

Catalog No. :
ACIQNX316
CAS No. :
2493287-96-8
Molecular Formula :
C30H30NO4P
Molecular Weight :
499.55

IUPAC Name:dimethyl 3,3'-(2-(2-(diphenylphosphaneyl)-1H-pyrrol-1-yl)-1,3-phenylene)dipropionate

Dimethyl 3,3'-(2-(2-(diphenylphosphanyl)-1H-pyrrol-1-yl)-1,3-phenylene)dipropionate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDimethyl 3,3'-(2-(2-(diphenylphosphanyl)-1H-pyrrol-1-yl)-1,3-phenylene)dipropionate
IUPAC Namedimethyl 3,3'-(2-(2-(diphenylphosphaneyl)-1H-pyrrol-1-yl)-1,3-phenylene)dipropionate
Molecular FormulaC30H30NO4P
Molecular Weight499.55
SMILESO=C(CCC1=CC=CC(CCC(OC)=O)=C1N2C=CC=C2P(C3=CC=CC=C3)C4=CC=CC=C4)OC
InChI KeyCYHRNLZBBINKMN-UHFFFAOYSA-N
Synonymdimethyl 3,3'-(2-(2-(diphenylphosphanyl)-1H-pyrrol-1-yl)-1,3-phenylene)dipropionate;1,3-Benzenedipropanoic acid, 2-[2-(diphenylphosphino)-1H-pyrrol-1-yl]-, 1,3-dimethyl ester;dimethyl 3,3'-(2-(2-(diphenylphosphanyl) -1H-pyrrol-1-yl)-1,3-phenylene)dipropionate
CAS No.2493287-96-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIQNX316 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIQNX316 route product structure diagram
    ACIQNX3162493287-96-8
Inquiry

2. ACIQNX316 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIQNX316 route product structure diagram
    ACIQNX3162493287-96-8
Inquiry

Comments (0)